Ulrik Niels Lassen
Clinical Professor
1 - 4 out of 4Page size: 10
- 2008
- Published
Phase II study of a 3-day schedule with topotecan and cisplatin in patients with previously untreated small cell lung cancer and extensive disease
Sorensen, M., Lassen, Ulrik Niels, Jensen, P. B., Østerlind, K., Jeppesen, N., Jensen, B. B., Mellemgaard, A., Rytter, C. & Langer, Seppo W., Aug 2008, In: Journal of Thoracic Oncology. 3, 8, p. 902-6 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial
Sorensen, M., Lassen, Ulrik Niels, Palshof, T., Jensen, B. B., Johansen, J., Jensen, P. B. & Langer, Seppo W., May 2008, In: Lung Cancer. 60, 2, p. 252-8 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Phase II study of a 3-day schedule with topotecan and cisplatin in patients with previously untreated small cell lung cancer and extensive disease
Sorensen, M., Lassen, Ulrik Niels, Jensen, P. B., Østerlind, K. E., Jeppesen, N., Jensen, B. B., Mellemgaard, A., Rytter, C. & Langer, Seppo W., 2008, In: Journal of Thoracic Oncology. 3, 8, p. 902-906 4 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial
Sorensen, M., Lassen, Ulrik Niels, Palshof, T., Jensen, B. B., Johansen, J., Jensen, P. B. & Langer, S. W., 2008, In: Lung Cancer. 60, 2, p. 252-258 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 4952653
Most downloads
-
479
downloads
Clinical trial allocation in multinational pharmaceutical companies: a qualitative study on influential factors
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
223
downloads
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
174
downloads
Hallmarks of glioblastoma: a systematic review
Research output: Contribution to journal › Review › Research › peer-review
Published